ERBB2 and breast cancer: Triple negative breast cancer (TNBC), defined as breast cancer cells lacking expression of oestrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 (HER2), accounts for up to 20% of all breast cancer.